SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Dwight D. Eisenhower — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientDwight D. Eisenhower
Date of birth1890-10-14
IdentifiersMRN HR-ET015-SYN-TD; SSN (made up) 000-15-2673
Document date1956-01-26
AuthorRussell Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week blood pressure and kidney check after increasing lisinopril. [S]

History of Present Illness

Mr. Eisenhower returns two weeks after lisinopril was increased to 10 mg and ezetimibe was added. He has had no dizziness, cough, or muscle aches. His home blood pressure has been 124 to 130 over 76 to 80. He is still working half days and walks 40 minutes most days without chest pain or breathlessness. He has not needed nitroglycerin. His echocardiogram and cardiology consultation were done this morning, and he was told he can return to full-time work; he plans to start next week. [S]

ElementDetail
Interval changeNo symptoms on the higher lisinopril dose or on ezetimibe
Home blood pressure124 to 130 over 76 to 80
ExerciseWalking 40 minutes most days without angina
Nitroglycerin useNone
AdherenceEvery dose of aspirin, ticagrelor, atorvastatin, ezetimibe, metoprolol, and lisinopril
WorkHalf days; full-time return planned next week

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy improving; no fever
CardiovascularNegativeNo chest pain, palpitations, orthopnea, or ankle swelling
RespiratoryNegativeNo cough or breathlessness
MusculoskeletalNegativeNo muscle aches on statin and ezetimibe
NeurologicalNegativeNo dizziness on standing
HematologicPositiveEasy bruising on the forearms; no other bleeding

6 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aspirin 81 mg delayed-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1955-09-24activeS
Ticagrelor 90 mg oral tablet, one tablet by mouth twice dailyOne tablet by mouth twice dailyOral route1955-09-24 to 1956-09-28completedS
Atorvastatin 80 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1955-09-24activeS
Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1955-09-25activeS
Lisinopril 5 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1955-09-26 to 1956-01-12completedS
Lisinopril 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1956-01-12activeS
Ezetimibe 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1956-01-12activeS
Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tabletOne tablet under the tongue every 5 minutes as needed for chest pain, up to 3 dosesSublingual route1955-09-24activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1956-01-26Body height178cmS
1956-01-26Body weight78.6kgS
1956-01-26Body mass index (BMI) [Ratio]24.8kg/m2S
1956-01-26Systolic blood pressure128mm[Hg]S
1956-01-26Diastolic blood pressure78mm[Hg]S
1956-01-26Heart rate60/minS
1956-01-26Respiratory rate14/minS
1956-01-26Body temperature36.7CelS
1956-01-26Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1956-01-26Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1956-01-26Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
1956-01-26Creatinine [Mass/volume] in Serum or Plasma1.04mg/dL0.74-1.35 mg/dLNormalS
1956-01-26Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1951)/1.73 sq M80mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1956-01-26Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
1956-01-26Left ventricular Ejection fraction52%50-70%NormalS

Physical Exam

Vital signs recorded on 1956-01-26; see the Vital Signs section. [S]

SystemFinding
GeneralWell, alert, and eager to get back to work
NeckNo jugular venous distension; no carotid bruits
HeartRegular rhythm; no murmur or gallop
LungsClear
ExtremitiesNo edema; right radial access site healed

Problems

ProblemClinical statusVerificationCodeProvenance
Anterior ST-elevation myocardial infarction about four months before intake, treated with a drug-eluting stent to the left anterior descending artery; synthetic modern episode linked to the documented 1885 anterolateral infarctionactiveconfirmed I25.2S — Synthetic modern diagnosis; the 1955 infarction remains D in the history.
Coronary artery disease, single-vessel, after stenting; no anginaactiveconfirmed I25.10S — Synthetic diagnosis supporting secondary prevention.
Hyperlipidemia, on high-intensity statinactiveconfirmed E78.5S — Synthetic diagnosis; no cholesterol value from his lifetime is used.
Essential hypertensionactiveconfirmed I10S — Synthetic diagnosis; no blood pressure from his lifetime is used.
Former heavy cigarette smoker, quit about seven years before intakeactiveconfirmed Z87.891S — Synthetic coded history echoing the documented heavy smoking and quitting around 1949.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryBasic metabolic panel (potassium, creatinine, eGFR)1 to 2 weeks after starting or changing an ACE inhibitor, then every 6 monthsCompleted todayTwo weeks after lisinopril was increased to 10 mg. Potassium 4.6, creatinine 1.04 mg/dL, eGFR 80; normal
ImagingEchocardiogram for LVEF reassessment about 40 days after the infarctionOnce, about 40 days after the infarction, when the hospital LVEF was reducedDeferredThe hospital ejection fraction was 45 percent, so a repeat was due about 40 days after the infarction, before he established care here; it was not done. Done today at about four months instead: LVEF 52 percent, so no defibrillator evaluation is needed and no harm resulted. Corrective action: discharge plans from outside hospitals are now reconciled at the intake visit
ImagingTransthoracic echocardiogramReassess with clinical changeCompleted todayLVEF 52 percent, mild apical hypokinesis, no thrombus or aneurysm, normal valves
LaboratoryLipid panel4 to 12 weeks after starting or changing therapy, then every 3 to 12 monthsDueEzetimibe added two weeks ago; recheck in about two months
ExaminationBlood pressure, heart rate, weight and BMI, heart and lungs, edemaEvery visitCompleted todayBlood pressure 128/78 mmHg, heart rate 60, weight 78.6 kg
Medication safetyAntiplatelet, statin, beta-blocker, and ACE inhibitor adherence and toleranceEvery visitCompleted todayTaking all doses; forearm bruising only; no cough, dizziness, or myalgia
ReferralCardiology evaluationAfter the infarction, to establish local cardiology careCompleted todaySeen today; cleared for full-time work and long-distance travel
ReferralCardiac rehabilitationWithin 12 months of the infarction; 36 sessionsCompleted todayAll 36 phase 2 sessions completed; exit test 9 METs. Continues a home maintenance program
SurveyDepression screen (PHQ-2)Every visitUp to dateScore 1 at intake two weeks ago; repeat at the lipid review
Self-managementTobacco useEvery visitCompleted todayAbstinent; no exposure at work or home
Self-managementPhysical activity and Mediterranean-style dietEvery visitCompleted todayWalking 40 minutes most days; diet reviewed
ExaminationDefibrillator evaluationAt least 40 days after the infarction and 90 days after revascularization if LVEF is 35 percent or lessNot indicatedLVEF 52 percent

Goal progress:

Guideline basis: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes (2025); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); CMID: Clinical Monitoring Intelligence Database, acute myocardial infarction, ischemic heart disease, hyperlipidemia, and hypertension monographs (2026)

Follow-up: Lipid panel and review in about two months. Call for chest pain that does not settle with one nitroglycerin tablet in 5 minutes. Next scheduled visit 1956-03-16: lipid review nine weeks after adding ezetimibe. [S]